이상반응 보고

VAERS ID	2296237
성별	남성
나이	22세
주 코드	FR
제약회사	JANSSEN
로트 번호	XE444
예방접종 횟수	1
접종일	2021-12-06
발병일	2021-12-08
상태

증상

• 가려움증(Pruritus)

이환 중 질병

지병

기타 의료

이전 예방접종

알레르기

임상 검사

증상 상세

ITCHING ALL OVER; This spontaneous report received from a consumer via a Regulatory Authority, (Health Products Regulatory Authority) (ZA-SAHPRA-300063079) concerned a 22 year old male of an unspecified race and ethnicity.
The patient's height, and weight were not reported.
No past medical history or concurrent conditions were reported.
The patient received covid-19 vaccine ad26.
cov2.
s (suspension for injection, route of admin not reported, batch number: XE444 expiry: UNKNOWN) dose was not reported, 1 total administered on 06-DEC-2021 for an unspecified indication.
The age at time of vaccination was 22 years old.
No concomitant medications were reported.
On 08-DEC-2021, the patient experienced itching all over.
It was reported that the patient itching had gotten worse by spreading and was accompanied by pain.
Furthermore, the vaccinated arm had progressively become worse and pain killers did not seem to work.
The patient had given up on the pain killers and was going with the flow of pain, which was going on for straight 5 days and had no signs of it getting better.
The action taken with covid-19 vaccine ad26.
cov2.
s was not applicable.
The patient had not recovered from itching all over.
This report was serious (Other Medically Important Condition).
; Sender's Comments: V0:20220546016-Covid-19 vaccine ad26.
cov2.
s- itching all over.
The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility.
There is no information on any other factors potentially associated with the event(s).
Therefore, this event(s) is considered unassessable